Abstract
Objective
In chronic heart failure (CHF) episodes of decompensation may be linked to derangements within cardiovascular reflex control. We investigated changes in autonomic tone in patients with decompensated CHF.
Methods
We examined 17 patients with decompensated CHF (14 men, age 62 ± 2 years, LVEF 32 ± 3%) on admission and after clinical stabilization. Control group consisted of 9 patients (8 men, age 64 ± 7 years, LVEF 30 ± 7%) with stable CHF. Assessment of autonomic tone was based on 5-min ECG and blood pressure recordings using time and frequency domains of heart rate variability (HRV) and a sequence method to derive baroreflex sensitivity (BRS).
Results
On admission, decompensated CHF patients had reduced HRV indices (p < 0.05) and depressed BRS (p < 0.01) as compared to those with stable CHF. After clinical stabilization (4 ± 2 days of treatment) time domain HRV indices and BRS increased (SDNN, 34.4 ± 5.4 vs. 55.8 ± 9.8 ms; RMSSD, 38.4 ± 12.0 vs. 51.1 ± 10.4 ms; BRS, 4.3 ± 0.7 vs. 7.6 ± 1.3 ms/mmHg; all p < 0.01) and became similar to those seen in stable CHF patients. Breathing with oxygen affected autonomic indices neither in decompensated nor in stable CHF patients. Eight patients developed an episode of additional CHF worsening during hospitalization, in whom the third assessment was performed on discharge. Worsening in clinical status was followed by a decrease in HRV and BRS that became similar to those noted on admission.
Interpretation
HRV measures and BRS are severely deranged in the acute phase of CHF decompensation. Clinical stabilization results in an improvement of autonomic indices. However, subsequent clinical worsening adversely affects HRV and BRS.
Similar content being viewed by others
References
Gheorghiade M, Pand PS (2009) Acute heart failure syndromes. J Am Coll Cardiol 59(7):557–573
Gheorghiade M, Zannad F, Sopko G et al (2005) Acute heart failure syndromes: current state and framework for future research. Circulation 112:3958–3968
Adams KF Jr, Fonarow GC, Emerman CL et al (2005) Characteristics and outcomes of patients hospitalised for heart failure in the United States: rationale, design, and preliminary observations from the first 1,000,000 cases in the Acute Decompensated heart Failure National Registry (ADHERE). Am Heart J 149:209–216
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Eur Heart J 29(19):2388–2442
Fonarow GC, Stough WG, Abraham WT et al (2007) Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalised for heart failure: a report from the OPTIMIZE-HF registry. J Am Coll Cardiol 50:768–777
Fonarow GC, Abraham WT, Albert NM et al (2007) Association between performance measures and clinical outcomes of patients hospitalized with heart failure. JAMA 297:61–70
Jankowska EA, Ponikowski P, Piepoli MF, Banasiak W, Anker SD, Poole-Wilson PA (2006) Autonomic imbalance and immune activation in chronic heart failure—pathophysiological links. Cardiovasc Res 70:434–445
Mann DL (1999) Mechanisms and models in heart failure: a combinatorial approach. Circulation 100:999–1008
Braunwald E, Bristow MR (2000) Congestive heart failure: fifty years of progress. Circulation 102: IV14
Floras JS (2003) Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. Acta Physiol Scand 75:15–21
Massie BM (1988) Is neurohormonal activation deleterious to the long-term outcome of patients with congestive heart failure? J Am Coll Cardiol 12:547–558
Francis GS, Rector TS, Cohn JN (1988) Sequential neurohormonal measurements in patients with congestive heart failure. Am Heart J 116:1464–1468
Harris P (1987) Congestive heart failure: central role of arterial blood pressure. Br Heart J 58:190–203
Benedict CR, Shelton B, Johnstone DE, Francis G, Breenberg B, Konstam M et al (1996) Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation 82:1724–1729
Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS et al (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of left Ventricular Dysfunction (SOLVD). Circulation 82:1724–1729
Rouleau JL, de Champlain J, Klein M, Bichet D, Moye L, Packer M et al (1993) Activation of neurohumoral systems in postinfarction left ventricular dysfunction. J Am Coll Cardiol 22:390–398
Hunt SA (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart association Task Force on Practice Guidelines. J Am Coll Cardiol 46:e1–e82
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043–1065
Ponikowski P, Chua TP, Piepoli M, Banasiak W, Anker SD, Szelemej R, Molenda W, Wrabec K, Capucci A, Coats AJ (1998) Ventilatory response to exercise correlates with impaired heart rate variability in patients with chronic congestive heart failure. Am J Cardiol 82(3):338–344
Davies LC, Francis DP, Scott AC, Ponikowski P, Piepoli M, Coats AJ (2001) Effect of altering conditions of the sequence method on baroreflex sensitivity. J Hypertens 19:1279–1287
Lanfranchi PA, Somers VK (2002) Arterial baroreflex function and cardiovascular variability: interactions and implications. Am J Physiol Regul Integr Comp Physiol 283:815–826
Lipman RD, Salisbury JK, Taylor JA (2003) Spontaneous indices are inconsistent with arterial baroreflex gain. Hypertension 42(4):481–487
Chua TP, Ponikowski PP, Harrington D, Chambers J, Coats AJ (1996) Contribution of peripheral chemoreceptors to ventilation and the effects of their suppression on exercise tolerance in chronic heart failure. Heart 76:483–489
Matveev M, Prokopova R (2008) Prognostic value of the time related autonomic balance indicator for risk evaluation of cardiovascular events in patients with ischemic heart disease. Comput Cardiol 35:201–204
Mancia G, Grassi G, Bertinieri G, Ferrari A, Zanchetti A (1984) Arterial baroreceptor control of blood pressure in man. J Auton Nerv Syst 11(2):115–124
Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, Webb-Peploe K, Harrington D, Banasiak W, Wrabec K, Coats AJ (1997) Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 79:1645–1650
Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN (1992) Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol 69:891–898
Farrell TG, Odemuyiwa O, Bashir Y, Cripps TR, Malik M, Ward DE, Camm AJ (1992) Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Heart J 67(2):129–137
Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA (1998) Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart failure Evaluation and Assessment of Risk Trial. Circulation 98:1510–1516
Osterziel KJ, Hänlein D, Willenbrock R, Eichhorn C, Luft F, Dietz R (1995) Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure. Br Heart J 73:517–522
Ponikowski P, Chua TP, Anker SD, Francis DP, Doehner W, Banasiak W et al (2001) Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 104:544–549
Adamsom PB, Kleckner KJ, VanHout WL, Srinivasan S, Abraham WT (2003) Cardiac resynchronization therapy improves heart rate variability In patients with symptomatic heart failure. Circulation 108:266–269
Landolina M, Gasparini M, Lunati M, Santini M, Rordorf R, Vincenti A, Diotallevi P, Montenero AS, Bonanno C, De Santo T, Valsecchi S, Padeletti L (2008) Heart rate variability monitored by the implanted device predicts response to CRT and long-term clinical outcome In patients with advanced heart failure. Eur J Heart Fail 10:1073–1079
Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC (2006) Clinical presentation, management and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database. J Am Coll Cardiol 47:76–84
Grassi G, Mancia G (1994) Neurohumoral mechanisms in cardiocirculatory decompensation. Ann Ital Med Int 9:61S–67S
Aronson D, Mittleman MA, Burger AJ (2004) Measures of heart period variability as predictors of mortality in hospitalized patients with decompensated congestive heart failure. Am J Cardiol 93(1):59–63
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rydlewska, A., Jankowska, E.A., Ponikowska, B. et al. Changes in autonomic balance in patients with decompensated chronic heart failure. Clin Auton Res 21, 47–54 (2011). https://doi.org/10.1007/s10286-010-0089-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10286-010-0089-z